The Notch Pathway in Breast Cancer Progression

Abstract EN

Objective.

Notch signaling pathway is a vital parameter of the mammalian vascular system.

In this review, the authors summarize the current knowledge about the impact of the Notch signaling pathway in breast cancer progression and the therapeutic role of Notch’s inhibition.

Methods.

The available literature in MEDLINE, PubMed, and Scopus, regarding the role of the Notch pathway in breast cancer progression was searched for related articles from about 1973 to 2017 including terms such as “Notch,” “Breast Cancer,” and “Angiogenesis.” Results.

Notch signaling controls the differentiation of breast epithelial cells during normal development.

Studies confirm that the Notch pathway has a major participation in breast cancer progression through overexpression and/or abnormal genetic type expression of the notch receptors and ligands that determine angiogenesis.

The cross-talk of Notch and estrogens, the effect of Notch in breast cancer stem cells formation, and the dependable Notch overexpression during breast tumorigenesis have been studied enough and undoubtedly linked to breast cancer development.

The already applied therapeutic inhibition of Notch for breast cancer can drastically change the course of the disease.

Conclusion.

Current data prove that Notch pathway has a major participation and multiple roles during breast tumor progression.

Inhibition of Notch receptors and ligands provides innovative therapeutic results and could become the therapy of choice in the next few years, even though further research is needed to reach safe conclusions.